Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Jan;58(1):109. doi: 10.1136/jnnp.58.1.109

Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis.

K Ray-Chaudhuri, C Smith, A C Gough, N Novak, V Chamoun, C R Wolf, P N Leigh
PMCID: PMC1073285  PMID: 7823053

Full text

PDF

Page 109

109

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fleming C. M., Branch R. A., Wilkinson G. R., Guengerich F. P. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4. Mol Pharmacol. 1992 May;41(5):975–980. [PubMed] [Google Scholar]
  2. Jacqz E., Hall S. D., Branch R. A. Genetically determined polymorphisms in drug oxidation. Hepatology. 1986 Sep-Oct;6(5):1020–1032. doi: 10.1002/hep.1840060534. [DOI] [PubMed] [Google Scholar]
  3. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  4. Swash M., Leigh N. Criteria for diagnosis of familial amyotrophic lateral sclerosis. European FALS Collaborative Group. Neuromuscul Disord. 1992;2(1):7–9. doi: 10.1016/0960-8966(92)90020-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES